Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-08 3:04 pm Purchase |
2024-12-13 | 13G | Palvella Therapeutics, Inc. PVLA |
Frazier Life Sciences Public Fund, L.P. | 575,892 5.100% |
575,892 (New Position) |
Filing History |
| 2024-12-20 5:32 pm Purchase |
2024-12-13 | 13D | Palvella Therapeutics, Inc. PVLA |
Kaupinen Wes | 1,644,869 14.600% |
1,644,869 (New Position) |
Filing History |
| 2024-12-20 4:59 pm Purchase |
2024-12-13 | 13G | Palvella Therapeutics, Inc. PVLA |
Samsara BioCapital, L.P. | 679,486 6.100% |
679,486 (New Position) |
Filing History |
| 2024-12-20 4:56 pm Purchase |
2024-12-13 | 13G | Palvella Therapeutics, Inc. PVLA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 714,463 8.600% |
714,463 (New Position) |
Filing History |
| 2024-12-17 5:42 pm Purchase |
2024-12-13 | 13G | Palvella Therapeutics, Inc. PVLA |
BIOTECHNOLOGY VALUE FUND L P | 1,168,117 9.990% |
1,168,117 (New Position) |
Filing History |
| 2024-12-17 4:22 pm Purchase |
2024-12-13 | 13G | Palvella Therapeutics, Inc. PVLA |
Dellora Investments Master Fund LP | 141,079 1.300% |
141,079 (New Position) |
Filing History |
| 2024-12-06 2:21 pm Purchase |
2024-11-06 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Dellora Investments Master Fund LP | 141,079 10.700% |
32,105 (+29.46%) |
Filing History |
| 2024-11-14 09:07 am Sale |
2024-09-30 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Lynx1 Capital Management LP | 37,436 2.800% |
-84,762 (-69.36%) |
Filing History |
| 2024-08-07 2:16 pm Purchase |
2024-07-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Dellora Investments Master Fund LP | 108,974 8.300% |
108,974 (New Position) |
Filing History |
| 2024-08-01 08:00 am Purchase |
2024-07-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
ADAR1 Capital Management, LLC | 138,641 10.500% |
138,641 (New Position) |
Filing History |
| 2024-05-17 5:07 pm Unchanged |
2024-05-15 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 257,622 19.500% |
0 (Unchanged) |
Filing History |
| 2024-05-17 5:07 pm Purchase |
2024-05-15 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 257,622 19.500% |
257,622 (New Position) |
Filing History |
| 2024-02-14 4:37 pm Sale |
2023-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Aquilo Capital Management LLC | 14,085 1.100% |
-56,911 (-80.16%) |
Filing History |
| 2024-02-14 1:12 pm Sale |
2023-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Checkpoint Capital L.P. | 0 0.000% |
-61,731 (Position Closed) |
Filing History |
| 2024-02-14 09:19 am Purchase |
2023-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Lynx1 Capital Management LP | 122,198 9.900% |
51,841 (+73.68%) |
Filing History |
| 2024-02-02 09:59 am Sale |
2023-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Soleus Capital Master Fund, L.P. | 0 0.000% |
-50,000 (Position Closed) |
Filing History |
| 2023-08-17 4:49 pm Unchanged |
2023-08-10 | 13D | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 257,623 20.800% |
0 (Unchanged) |
Filing History |
| 2023-06-09 5:40 pm Purchase |
2023-06-01 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Checkpoint Capital L.P. | 61,731 6.000% |
61,731 (New Position) |
Filing History |
| 2023-05-22 4:47 pm Purchase |
2023-05-11 | 13D | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 257,623 22.000% |
161,448 (+167.87%) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Lynx1 Capital Management LP | 70,357 7.600% |
22,550 (+47.17%) |
Filing History |